Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
UniViforcit is a nutritional supplement developed and marketed by Uni-Pharma (Syria). It is primarily used for vitamin and mineral supplementation to support the immune system and address nutritional deficiencies. The product line includes formulations such as UniViforcit Zn, which combines Vitamin C (ascorbic acid) and Zinc. These components act as antioxidants and essential cofactors in various enzymatic processes. Vitamin C is a necessary cofactor for collagen synthesis and immune cell function, while Zinc is an essential trace element involved in DNA synthesis, cell division, and immune system maintenance. It is indicated for the prevention and treatment of vitamin and mineral deficiencies, particularly during periods of increased physiological demand or reduced intake.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on UniViforcit.